Clinical Trials Directory

Trials / Completed

CompletedNCT02360540

PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability

Performance of the Pulmonary Embolism Rule-out Criteria (the PERC Rule) Combined With Implicit Low Clinical Probability (Gestalt) to Rule-out PE Without Further Exams

Status
Completed
Phase
Study type
Observational
Enrollment
1,773 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

PERC rule was created to rule out pulmonary embolism (PE) without further exams, with residual PE risk \<2%. Its safety is currently confirmed in low PE prevalence populations as north-American. In European high PE prevalence population, it has been showed that PERC rule used alone or associated with low clinical probability assessed by revised Geneva score (RGS) was not safe. In retrospective study, we suggest that the combination of PERC rule with implicit clinical probability (gestalt) could allow the use of the PERC rule. PERCEPIC, an observational prospective multicenter study performed in France and Belgium, will test this hypothesis. Therefore, 3000 patients will be included in 12 centers. Primary outcome will be the rate of thromboembolic events or death related or possibly related to PE in patients with low implicit clinical probability and negative PERC rule (8 criteria absents). Upper limit of confidence interval of this rate must be equal or lower than 3% to consider PERC rule as safe in this combination.

Conditions

Interventions

TypeNameDescription
OTHERGestalt estimation

Timeline

Start date
2015-05-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-02-10
Last updated
2016-09-22

Locations

12 sites across 2 countries: Belgium, France

Source: ClinicalTrials.gov record NCT02360540. Inclusion in this directory is not an endorsement.